t(3;5)(q21;q31) in a myelodysplastic syndrome.

Cytogenetic analysis from the bone marrow of a patient with a myelodysplastic syndrome revealed the balanced translocation t(3;5)(q21;q31). Although this translocation has recently been described in six cases of AML, this is the first such observation in a preleukaemic syndrome. Subsequent evolution into RAEB and AML(M2) was noted without the acquisition of additional cytogenetic changes and complete remission achieved with conventional cytotoxic chemotherapy. The relationships with other acquired abnormalities of chromosomes 3 and 5 in MDS/AML are discussed.
AuthorsR A Sharp, J Robertson, A D Heppleston
JournalLeukemia research (Leuk Res) Vol. 11 Issue 7 Pg. 629-33 ( 1987) ISSN: 0145-2126 [Print] ENGLAND
PMID3475514 (Publication Type: Case Reports, Journal Article)
  • Adult
  • Anemia, Refractory, with Excess of Blasts (genetics)
  • Blast Crisis (genetics)
  • Bone Marrow (pathology)
  • Chromosomes, Human, Pair 3 (ultrastructure)
  • Chromosomes, Human, Pair 5 (ultrastructure)
  • Humans
  • Leukemia, Myeloid, Acute (genetics)
  • Male
  • Myelodysplastic Syndromes (genetics)
  • Preleukemia (genetics)
  • Translocation, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: